New antiepileptic drugs: New therapeutic options;Les nouveaux anti-épileptiques: 10 Ans après

Revue Neurologique

Volumn 158, Issue 5 II, 2002, Pages

  Baulac, Michel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHINYLESTRADIOL; ETIRACETAM; FELBAMATE; GABAPENTIN; GESTAGEN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ANTICONVULSANT THERAPY; COGNITION; CONFERENCE PAPER; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MYOCLONUS; PROGNOSIS; TOXICITY; TREATMENT OUTCOME;

ANTICONVULSANTS; BRAIN; EPILEPSY; HUMANS;

EID: 0036113278     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. European experience with the use of vigabatrin as first-line monotherapy in infantile spasms
2. Clinical experience with vigabatrin in 401 outpatients with non severe partial epilepsy
3. The development of a seizure severity scale as an outcome measure in epilepsy
4. Severe visual-field constriction and side-effects of GABA-mimetic antiepileptic agents
5. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: An open, observational study
6. Communication of pooled results of 27 open studies of lamotrigine as add-on therapy for up to 12 months in adults with treatment resistant epilepsy
7. Vigabatrin: Clinical evidence supporting rational polytherapy in management of uncontrolled seizures
8. Important pharmacokinetic properties of antiepileptic drugs
9. Lamotrigine
10. Multicentre, double blind, randomized comparison between lamotrigine carbamzepine in elderly patients with newly diagnosed epilepsy
11. Management of epilepsy in adolescents and adults
12. Antiepileptic drugs, clinical trials, and the marketplace
13. Therapeutic trial of vigabatrin in refractory infantile spasms
14. Vigabatrin versus hydrocortisone as first-line monotherapy in infantile spasms due to tuberous sclerosis
15. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial
16. New antiepileptic drugs: Comparison of key clinical triales
17. Oxcarbazepine
18. Surgery for seizures
19. Relating pharmacology to clinical practice: The pharmacologic basis of rational polypharmacy
20. Antiepileptic drug-induced worsening of seizures in adults and children
21. Seizure disorders: The changes with age
22. Lamotrigine and generalized epileptic sydnromes
23. Laboratory monitoring of antiepileptic drugs
24. Neuropsychological effects of epilepsy and anti epileptic drugs
25. Behavioral side effects of gabapentin in children
26. New antiepileptic drugs: A systematic review of their efficacy and tolerability
27. Vigabatrin: Effects on human brain GABA levels by nuclear magnetic resonance spectroscopy
28. Response to vigabatrin in relation to seizure type
29. Meta-analysis of placebo-controlled studies of vigabatrin in drug resistant epilepsy
30. Lamotrigine in treatment of 120 children with epilepsy
31. Lamotrigine: Preliminary clinical observations on pharmacokinetics and interactions with traditional antiepileptic drugs
32. Sodium valproate acutely inhibits lamotrigine metabolism